TABLE 6. Incidence rates* and percentages† of invasive colon and rectal cancers, by demographic and tumor characteristics — United States,§ 2010–2014.
| Demographic characteristic | Total |
Male |
Female |
|||
|---|---|---|---|---|---|---|
| No. | Rate (95% CI) | No. | Rate (95% CI) | No. | Rate (95% CI) | |
|
Total
|
689,738
|
39.8 (39.7–39.9)
|
358,980
|
45.8 (45.6–45.9)
|
330,758
|
34.8 (34.7–34.9)
|
|
Age group at diagnosis (yrs)
| ||||||
| <40 |
19,731 |
2.6 (2.5–2.6) |
9,987 |
2.6 (2.5–2.6) |
9,744 |
2.5 (2.5–2.6) |
| 40–49 |
52,570 |
24.3 (24.1–24.5) |
28,010 |
26.1 (25.8–26.5) |
24,560 |
22.5 (22.3–22.8) |
| 50–59 |
132,893 |
61.5 (61.2–61.8) |
74,955 |
71.0 (70.5–71.5) |
57,938 |
52.5 (52.0–52.9) |
| 60–69 |
167,619 |
107.8 (107.3–108.3) |
96,144 |
130.0 (129.2–130.9) |
71,475 |
87.6 (87.0–88.3) |
| 70–79 |
162,100 |
186.3 (185.4–187.3) |
85,303 |
218.0 (216.6–219.5) |
76,797 |
160.5 (159.3–161.6) |
| ≥80 |
154,825 |
267.2 (265.9–268.5) |
64,581 |
302.4 (300.0–304.7) |
90,244 |
246.3 (244.7–248.0) |
|
Race
| ||||||
| White |
568,027 |
38.9 (38.8–39.0) |
297,149 |
44.7 (44.5–44.8) |
270,878 |
33.9 (33.8–34.1) |
| Black |
84,797 |
46.7 (46.4–47.1) |
42,304 |
55.1 (54.6–55.7) |
42,493 |
40.9 (40.5–41.3) |
| American Indian/Alaska Native |
4,533 |
30.9 (29.9–31.9) |
2,367 |
34.7 (33.2–36.3) |
2,166 |
27.8 (26.6–29.0) |
| Asian/Pacific Islander |
24,651 |
31.4 (31.0–31.8) |
12,927 |
37.0 (36.3–37.6) |
11,724 |
27.0 (26.5–27.5) |
|
Ethnicity¶
| ||||||
| Hispanic |
54,664 |
35.0 (34.7–35.3) |
29,604 |
42.0 (41.5–42.6) |
25,060 |
29.4 (29.0–29.8) |
| Non-Hispanic |
635,010 |
40.3 (40.2–40.4) |
329,348 |
46.3 (46.2–46.5) |
305,662 |
35.4 (35.3–35.5) |
|
County classification
| ||||||
| Metropolitan |
550,090 |
39.1 (39.0–39.2) |
284,709 |
45.0 (44.8–45.2) |
265,381 |
34.2 (34.1–34.3) |
| Nonmetropolitan |
107,117 |
43.1 (42.8–43.4) |
56,914 |
49.3 (48.9–49.8) |
50,203 |
37.7 (37.4–38.0) |
|
Census region
| ||||||
| Northeast |
134,889 |
40.8 (40.5–41.0) |
67,880 |
46.7 (46.3–47.0) |
67,009 |
36.0 (35.7–36.3) |
| Midwest |
160,438 |
41.6 (41.4–41.8) |
83,150 |
48.0 (47.6–48.3) |
77,288 |
36.4 (36.1–36.6) |
| South |
259,826 |
40.0 (39.9–40.2) |
137,204 |
46.6 (46.3–46.8) |
122,622 |
34.7 (34.5–34.9) |
| West |
134,585 |
36.3 (36.1–36.5) |
70,746 |
41.4 (41.1–41.7) |
63,839 |
32.0 (31.8–32.3) |
|
Tumor characteristic**
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
Total
|
663,134
|
100.0
|
346,670
|
100.0
|
316,464
|
100.0
|
|
Histology
| ||||||
| Adenocarcinoma |
450,086 |
67.9 |
237,862 |
68.6 |
212,224 |
67.1 |
| Adenoma |
115,940 |
17.5 |
62,459 |
18.0 |
53,481 |
16.9 |
| Mucinous carcinoma |
50,295 |
7.6 |
24,365 |
7.0 |
25,930 |
8.2 |
| Carcinoid |
28,410 |
4.3 |
13,624 |
3.9 |
14,786 |
4.7 |
| Epithelial carcinoma, NOS |
7,140 |
1.1 |
3,723 |
1.1 |
3,417 |
1.1 |
| All other histologies |
11,263 |
1.7 |
4,637 |
1.3 |
6,626 |
2.1 |
|
Stage††
| ||||||
| Localized |
260,739 |
39.3 |
135,705 |
39.1 |
125,034 |
39.5 |
| Regional |
233,918 |
35.3 |
121,636 |
35.1 |
112,282 |
35.5 |
| Distant |
135,731 |
20.5 |
72,393 |
20.9 |
63,338 |
20.0 |
| Unknown | 32,746 | 4.9 | 16,936 | 4.9 | 15,810 | 5.0 |
Abbreviations: CI = confidence interval; NOS = not otherwise specified.
* New cases diagnosed per 100,000 persons, age adjusted to the 2000 U.S. standard population.
† New cases diagnosed.
§ Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.)
¶ Ethnicity is not mutually exclusive from race.
** Only includes microscopically confirmed cases; excludes cases identified only through death certificate or autopsy report.
†† Localized: cancer that is confined to the primary site; regional: cancer that has spread directly beyond the primary site or to regional lymph nodes; distant: cancer that has spread to other organs.